1. Home
  2. ELTX vs NUAI Comparison

ELTX vs NUAI Comparison

Compare ELTX & NUAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$9.91

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Logo New Era Energy & Digital Inc.

NUAI

New Era Energy & Digital Inc.

HOLD

Current Price

$4.88

Market Cap

211.2M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
NUAI
Founded
2011
N/A
Country
United States
United States
Employees
33
5
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
211.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ELTX
NUAI
Price
$9.91
$4.88
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$18.00
$11.00
AVG Volume (30 Days)
112.2K
6.4M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
N/A
EPS
N/A
N/A
Revenue
$2,301,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.80
$0.32
52 Week High
$14.93
$9.45

Technical Indicators

Market Signals
Indicator
ELTX
NUAI
Relative Strength Index (RSI) 38.27 58.65
Support Level $8.76 $4.10
Resistance Level $10.16 $5.23
Average True Range (ATR) 0.75 0.40
MACD -0.19 0.10
Stochastic Oscillator 2.14 77.93

Price Performance

Historical Comparison
ELTX
NUAI

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About NUAI New Era Energy & Digital Inc.

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

Share on Social Networks: